2-(3-Aminobicyclo[1.1.1]pentan-1-yl)acetic acid hydrochloride, 98%, 250mg

1-Chloro-3,5-di(propan-2-yl)benzene, 97%, 100mg

4-(1-Methyl-1H-imidazol-5-yl)benzoic acid, 95.0%, 100mg

(S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(((benzyloxy)carbonyl)amino)butanoic acid, 98%, 250mg

(5-Bromopyrimidin-2-yl)methanol, 95.0%, 250mg

Methyl 2-(m-tolyl)acetate, 95.0%, 1g

1-Vinylpyrrolidin-2-one (contains stabiliser), 95.0%, 100g

Methyl 4-amino-6-methylnicotinate, 95.0%, 100mg

4-Methylpyrimidine, 98.0%, 1g

Prolongación de vacío NS 14/23

2-Amino-1-naphthol hydrochloride, 98.0%, 5g

2-(2-Methyl-4-oxo-4 H -quinazolin-3-yl)-benzoic acid, 95.0%, 5g

4-(Trifluoromethoxy)-2,3-dihydro-1H-inden-1-one, 98%, 250mg